The post ORBS Surges 10% in Pre-Market as Eightco Holdings Announces $125 Million Share Buyback Plan appeared on BitcoinEthereumNews.com. COINOTAG News, DecemberThe post ORBS Surges 10% in Pre-Market as Eightco Holdings Announces $125 Million Share Buyback Plan appeared on BitcoinEthereumNews.com. COINOTAG News, December

ORBS Surges 10% in Pre-Market as Eightco Holdings Announces $125 Million Share Buyback Plan

COINOTAG News, December 29 — in early pre-market trading, Eightco Holdings (ORBS) surged more than 10%, lifting its market capitalization to about $329 million. The move reflects continued demand for crypto-adjacent equities and signals growing appetite for liquid assets among traders tracking blockchain-linked issuers.

On the corporate front, Eightco’s board of directors approved a share repurchase plan up to $125 million, a reaffirmation of capital-return discipline aimed at supporting shareholder value amid ongoing market volatility.

Investors will monitor how the buyback interacts with balance sheet fundamentals and growth strategy, with attention to timing and liquidity metrics. This development may bolster confidence in the stock’s resilience within digital asset ecosystems.

Source: https://en.coinotag.com/breakingnews/orbs-surges-10-in-pre-market-as-eightco-holdings-announces-125-million-share-buyback-plan

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.002734
$0.002734$0.002734
-3.63%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.